Paul Tudor Jones's DNA Position Overview
Paul Tudor Jones (via Tudor Investment Corp Et Al) currently holds 464,663 shares of Ginkgo Bioworks Holdings, Inc. (DNA) worth $2.85 M, representing 0.01% of the portfolio. First purchased in 2025-Q1, this short-term holding has been held for 4 quarters.
Based on 13F filings, Paul Tudor Jones has maintained this position in DNA for several quarters, showing initial confidence in the investment. Largest addition occurred in Q1 2026, adding 270,701 shares. Largest reduction occurred in Q2 2025, reducing 68,327 shares.
Analysis based on 13F filings available since 2013 Q2
Paul Tudor Jones's Ginkgo Bioworks Holdings (DNA) Holding Value Over Time
Track share changes against reported price movement
Quarterly Ginkgo Bioworks Holdings (DNA) Trades by Paul Tudor Jones
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +270,701 | Add 139.56% | 464,663 | $6.13 |
| Q4 2025 | +193,962 | New Buy | 193,962 | $8.31 |
| Q2 2025 | -68,327 | Sold Out | 0 | $0.00 |
| Q1 2025 | +68,327 | New Buy | 68,327 | $5.70 |
Paul Tudor Jones's Ginkgo Bioworks Holdings Investment FAQs
Paul Tudor Jones first purchased Ginkgo Bioworks Holdings, Inc. (DNA) in Q1 2025, acquiring 68,327 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones has held Ginkgo Bioworks Holdings, Inc. (DNA) for 4 quarters since Q1 2025.
Paul Tudor Jones's largest addition to Ginkgo Bioworks Holdings, Inc. (DNA) was in Q1 2026, adding 464,663 shares worth $2.85 M.
According to the latest 13F filing for Q1 2026, Paul Tudor Jones's firm, Tudor Investment Corp Et Al, owns 464,663 shares of Ginkgo Bioworks Holdings, Inc. (DNA), valued at approximately $2.85 M.
As of the Q1 2026 filing, Ginkgo Bioworks Holdings, Inc. (DNA) represents approximately 0.01% of Paul Tudor Jones's publicly disclosed stock portfolio, making it one of their key holdings.
Paul Tudor Jones's peak holding in Ginkgo Bioworks Holdings, Inc. (DNA) was 464,663 shares, as reported at the end of Q1 2026.